These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36974822)

  • 1. EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation.
    Ganesh D; Dafar A; Niklasson J; Sandberg I; Braz-Silva P; Sapkota D; Öhman J; Giglio D; Hasséus B
    Anticancer Res; 2023 Apr; 43(4):1533-1542. PubMed ID: 36974822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
    Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
    Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
    Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
    Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
    Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
    Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
    Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
    Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
    J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
    Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
    Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
    Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
    Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
    Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
    Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
    Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
    Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
    Tarle M; Müller D; Raguž M; Lukšić I
    Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
    Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
    Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
    Yu Q; Du Y; Wang S; Zheng X
    J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
    Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
    Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.